Biogen Will Acquire Revenue And Kidney Expertise With Apellis Purchase

Biogen is looking for near-term revenue, kidney expertise in buyout of Apellis (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business